Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 45.85%-8.31M | ---- | 24.74%-15.35M | ---- | -36.06%-20.39M | ---- | 3.69%-14.99M | ---- | 15.43%-15.56M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -160.00%-13K | ---- | ---5K | ---- | ---- | ---- | 99.73%-1K | ---- | 56.66%-371K |
| Impairment and provisions: | ---- | -86.63%1.39M | ---- | -25.58%10.43M | ---- | 231.72%14.02M | ---- | -36.06%4.23M | ---- | 19.93%6.61M |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | -29.74%274K | ---- | -85.57%390K | ---- | 180.87%2.7M | ---- | -22.67%962K |
| -Impairmen of inventory (reversal) | ---- | ---- | ---- | -13.97%8.16M | ---- | --9.48M | ---- | ---- | ---- | ---- |
| -Impairment of trade receivables (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---175K | ---- | ---- |
| -Other impairments and provisions | ---- | -30.30%1.39M | ---- | -51.75%2M | ---- | 144.11%4.15M | ---- | -69.93%1.7M | ---- | 32.35%5.65M |
| Asset sale loss (gain): | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 82.73%751K | ---- | 250.55%411K |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 82.73%751K | ---- | 250.55%411K |
| Depreciation and amortization: | ---- | 28.78%2.62M | ---- | -55.00%2.03M | ---- | -57.00%4.52M | ---- | -36.42%10.51M | ---- | -8.69%16.52M |
| Financial expense | ---- | 10.18%314K | ---- | -37.50%285K | ---- | -51.02%456K | ---- | -17.46%931K | ---- | -36.13%1.13M |
| Special items | ---- | ---- | ---- | ---- | ---- | 87.51%-766K | ---- | -88.13%-6.13M | ---- | ---3.26M |
| Operating profit before the change of operating capital | ---- | -53.55%-4M | ---- | -20.01%-2.6M | ---- | 53.93%-2.17M | ---- | -185.94%-4.71M | ---- | -6.21%5.48M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -85.99%136K | ---- | -63.34%971K | ---- | 128.70%2.65M | ---- | 52.90%-9.23M | ---- | -620.56%-19.6M |
| Accounts receivable (increase)decrease | ---- | 3,286.00%1.59M | ---- | -102.17%-50K | ---- | -61.04%2.31M | ---- | 1,357.32%5.92M | ---- | -144.02%-471K |
| Accounts payable increase (decrease) | ---- | 105.06%107K | ---- | -36.16%-2.12M | ---- | -132.22%-1.55M | ---- | 556.72%4.82M | ---- | 57.51%-1.06M |
| Special items for working capital changes | ---- | ---- | ---- | -202.06%-794K | ---- | 644.06%778K | ---- | -204.38%-143K | ---- | 159.05%137K |
| Cash from business operations | ---- | 52.94%-2.16M | ---- | -328.34%-4.59M | ---- | 160.26%2.01M | ---- | 78.49%-3.34M | ---- | -294.89%-15.51M |
| Special items of business | -1.46%-694K | ---- | 88.16%-684K | ---- | -8,929.69%-5.78M | ---- | 99.11%-64K | ---- | -272.61%-7.15M | ---- |
| Net cash from operations | -1.46%-694K | 52.94%-2.16M | 88.16%-684K | -328.34%-4.59M | -8,929.69%-5.78M | 160.26%2.01M | 99.11%-64K | 78.49%-3.34M | -272.61%-7.15M | -294.57%-15.51M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | 160.00%13K | ---- | --5K | --1K | ---- | ---- | -99.73%1K | ---- | -56.66%371K |
| Loan receivable (increase) decrease | ---- | ---- | ---- | ---- | ---359K | -111.11%-190K | ---- | ---90K | 903.33%301K | ---- |
| Sale of fixed assets | --800K | ---- | ---- | ---- | ---- | ---- | ---- | --310K | ---- | ---- |
| Purchase of fixed assets | ---- | ---- | ---- | -1,079.41%-802K | -1,430.00%-153K | 97.08%-68K | 99.27%-10K | -29.58%-2.33M | -327.59%-1.36M | -98.78%-1.8M |
| Other items in the investment business | -69.50%79K | ---- | --259K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from investment operations | 239.38%879K | 101.63%13K | 150.68%259K | -208.91%-797K | -5,010.00%-511K | 87.74%-258K | 99.06%-10K | -47.82%-2.11M | -5,415.00%-1.06M | -808.46%-1.42M |
| Net cash before financing | 143.53%185K | 60.14%-2.15M | 93.24%-425K | -407.42%-5.39M | -8,400.00%-6.29M | 132.21%1.75M | 99.10%-74K | 67.87%-5.44M | -297.31%-8.22M | -307.21%-16.94M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 171.87%1.8M | -25.00%6M | ---2.5M | 128.57%8M | ---- | -70.79%3.5M | ---10M | --11.98M | ---- | ---- |
| Refund | ---- | -21,012.50%-3.38M | ---- | 99.89%-16K | --9.5M | ---14.27M | ---- | ---- | ---- | ---- |
| Issuing shares | ---- | ---- | ---- | --7.71M | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from financing operations | 86.32%-751K | -132.75%-3.22M | -181.75%-5.49M | 156.91%9.84M | 159.20%6.72M | -497.58%-17.29M | -29.17%-11.34M | 80.85%-2.89M | 5.66%-8.78M | 5.09%-15.11M |
| Net Cash | 90.43%-566K | -220.70%-5.37M | -1,488.50%-5.92M | 128.64%4.45M | 103.73%426K | -86.38%-15.54M | 32.83%-11.42M | 73.99%-8.34M | -230.38%-17M | -313.71%-32.04M |
| Begining period cash | -86.82%815K | 256.28%6.19M | 256.28%6.19M | -89.95%1.74M | -89.95%1.74M | -32.55%17.27M | -32.55%17.27M | -55.58%25.61M | -55.58%25.61M | -11.84%57.65M |
| Cash at the end | -7.78%249K | -86.82%815K | -87.51%270K | 256.28%6.19M | -63.06%2.16M | -89.95%1.74M | -32.01%5.85M | -32.55%17.27M | -83.60%8.61M | -55.58%25.61M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.